June 2, 2016 — Here are the top 20 most popular current articles, news releases and videos on the Diagnostic and Interventional Cardiology (DAIC) magazine website from the month of May based on website analytics:

1. Updated ASE Guideline Simplifies Evaluation of Possible Heart Failure 

2. Abbott to Acquire St. Jude Medical 
CardioMEMS, heart failure, PA pressure monitoring
CardioMEMS, heart failure, PA pressure monitoring
SEEQ, wireless cardiac monitoring, cardiac wearable devices

Healthcare reform efforts of recent years have challenged the industry to reduce the costs of healthcare for both patients and providers while still maintaining a high quality of care. One of the largest drivers of cost has been repeat hospitalizations, and in 2012, the Centers for Medicare and Medicaid Services (CMS) established the Hospital Readmissions Reduction Program (HRRP) to begin solving the problem. 

The American Society of Echocardiography (ASE) will host its 27th Annual Scientific Sessions, June 10-14, 2016, at the Washington State Convention Center in Seattle.

BioVentrix Inc. announced that it has received a U.S. Food and Drug Administration (FDA) Investigational Device Exemption (IDE) approval to initiate its pivotal clinical trial, named ALIVE (American Less Invasive Ventricular Enhancement).

Biotronik announced the launch of CardioMessenger Smart in the United States. CardioMessenger Smart is a portable monitoring device, about the size of a modern smartphone, that keeps pacemaker, implantable cardioverter defibrillator (ICD) and insertable cardiac monitor (ICM) patients connected to their physician remotely, enabling more efficient care management anywhere in the world.

A person is admitted to the hospital with a stroke, but not much is known about whether or not that patient will undergo neuroimaging.

In a recent study, the use of a stent to repair pulmonary artery stenosis in children and adults with congenital heart disease was successful in the majority of patients, but many also experienced serious complications. The study was published in March in the Journal of the American College of Cardiology.

MIM Software Inc. announced it has received 510(k) U.S. Food and Drug Administration (FDA) clearance to market full MIM products running on tablets through thin client technology such as Citrix.

Medic Vision Imaging Solutions Ltd. announced the U.S. Food and Drug Administration (FDA) clearance of SafeCT-29 to help healthcare facilities achieve compliance as mandated by NEMA XR-29 Smart Dose standard.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now